VJHemOnc is committed to improving our service to you

EHA 2019 | Venetoclax resistance in CLL

VJHemOnc is committed to improving our service to you

Arnon Kater

From the educational session, Arnon Kater, PhD, of University of Amsterdam, Amsterdam, Netherlands, discusses tumor resistance to venetoclax in chronic lymphocytic leukemia (CLL). Recorded at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter